biotech · Genetic Disease · Alport Syndrome · ELOX
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals patent portfolio — 6 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Watertown, USA
- Founded
- 2013
- Employees
- 12
- Programs
- 7
- Drugs
- 1
- Patents
- 6
Eloxx Pharmaceuticals patents
6 pharmaceutical patents indexed for Eloxx Pharmaceuticals. 0 expire within 24 months.
Eloxx Pharmaceuticals has 6 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 11786539
Aminoglycoside derivatives and uses thereof in treating genetic disorders
granted -
US 11613551
Aminoglycoside derivatives and uses thereof in treating genetic disorders
granted -
US 11306115
Aminoglycoside derivatives and uses thereof in treating genetic disorders
granted -
US 10899785
Aminoglycoside derivatives and uses thereof in treating genetic disorders
granted -
US 10786520
Aminoglycoside derivatives and uses thereof in treating genetic disorders
granted -
US 10576095
Use of aminoglycoside analogs in the treatment of Rett syndrome
granted
Frequently asked questions
How many patents does Eloxx Pharmaceuticals have?
6 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Eloxx Pharmaceuticals patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.